Free Trial
→ Has Trump Finally Gone Too Far? (From Insiders Exposed) (Ad) Free LGND Stock Alerts

Ligand Pharmaceuticals (LGND) Insider Trading & Ownership

$103.68
-0.58 (-0.56%)
(As of 09/18/2024 ET)
Compare

Ligand Pharmaceuticals (NASDAQ:LGND) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
5.90%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$480,995.00
Number Of
Insiders Selling
(Last 12 Months)
5
Amount Of
Insider Selling
(Last 12 Months)
$5.59 M
Get LGND Insider Trade Alerts

Want to know when executives and insiders are buying or selling Ligand Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

LGND Insider Buying and Selling by Quarter

Ad True Gold Republic
Central Bank Abandons USD
Startling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – the United States Dollar… And placing a ‘quiet bet’ on a new type of currency… Gold.
Click here now to get your free 'Protect Your Wealth' Guide.

Ligand Pharmaceuticals Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/28/2024Andrew ReardonInsiderSell1,500$106.39$159,585.00  
8/26/2024Matthew E KorenbergCOOSell11,389$105.61$1,202,792.29  
8/22/2024Matthew E KorenbergCOOSell1,157$105.54$122,109.78  
8/9/2024Matthew E KorenbergCOOSell18,245$98.50$1,797,132.50  
8/8/2024Todd C DavisCEOBuy2,500$97.39$243,475.00  
5/17/2024Octavio EspinozaCFOSell5,156$86.66$446,818.96  
China Stockpiling Gold “Like No Tomorrow” (Ad)

For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a population of over 1.4 BILLION is “buying gold like there’s no tomorrow,” according to The New York Times. China, a rising global economic threat, aims to reduce its dependence on the US dollar… .

Click here now to get your free 'De-Dollarization' Guide.
5/15/2024Octavio EspinozaCFOSell5,873$86.01$505,136.73  
5/13/2024Matthew E KorenbergInsiderSell3,440$84.54$290,817.60  
5/9/2024Andrew ReardonInsiderSell10,000$83.04$830,400.00  
5/9/2024Nancy Ryan GrayDirectorSell934$83.20$77,708.80  
3/5/2024Stephen L SabbaDirectorSell1,893$74.30$140,649.90  
2/28/2024Octavio EspinozaCFOSell140$88.46$12,384.40  
9/22/2023Todd C DavisCEOBuy4,000$59.38$237,520.00  
(Data available from 1/1/2013 forward)

LGND Insider Trading Activity - Frequently Asked Questions

The list of insiders at Ligand Pharmaceuticals includes Andrew Reardon, John L Higgins, John W Kozarich, Matthew E Korenberg, Matthew W Foehr, Nancy Ryan Gray, Octavio Espinoza, Stephen L Sabba, and Todd C Davis. Learn more on insiders at LGND.

5.90% of Ligand Pharmaceuticals stock is owned by insiders. Learn more on LGND's insider holdings.

The following insider purchased LGND shares in the last 24 months: Todd C Davis ($480,995.00).

Insiders have purchased a total of 6,500 LGND shares in the last 24 months for a total of $480,995.00 bought.

The following insiders have sold LGND shares in the last 24 months: Andrew Reardon ($1,010,961.00), John L Higgins ($1,401,900.00), John W Kozarich ($833,673.28), Matthew E Korenberg ($3,412,852.17), Nancy Ryan Gray ($77,708.80), Octavio Espinoza ($1,092,625.53), and Stephen L Sabba ($634,898.94).

Insiders have sold a total of 98,983 Ligand Pharmaceuticals shares in the last 24 months for a total of $8,464,619.72 sold.

Ligand Pharmaceuticals Key Executives

  • Mr. Matthew E. Korenberg (Age 49)
    President & COO
    Compensation: $831.77k
    4 recent trades
  • Mr. Octavio Espinoza (Age 53)
    Chief Financial Officer
    Compensation: $613.59k
    2 recent trades
  • Mr. Andrew T. Reardon J.D. (Age 49)
    Chief Legal Officer & Secretary
    Compensation: $614.87k
  • Mr. Scott M. Plesha (Age 59)
    Chief Executive Officer
  • Mr. Paul J. Hadden
    Senior Vice President of Investments & Business Development
  • Simon Latimer
    Head of Investor Relations
  • Mr. Todd Pettingill
    Director of Corporate Development
  • Ms. Audrey Warfield-Graham
    Chief People Officer
  • Dr. Keith Marschke
    Senior Vice President of Biology & Scientific Affairs
  • Dr. Vincent D. Antle (Age 55)
    Senior Vice President of Technical Operations & QA - Capitsol

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:

This page (NASDAQ:LGND) was last updated on 9/18/2024 by MarketBeat.com Staff
From Our Partners
China Stockpiling Gold “Like No Tomorrow”
For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...
True Gold Republic | Sponsored
This diversified cannabis pioneer could make huge moves soon
The cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start ...
Greenlane | Sponsored
Tim Sykes’ Urgent Trade Alert: “Make this move now”
WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...
Timothy Sykes | Sponsored
Unlock the Secret to Easy Wins with Iron Condors
Discover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...
Netpicks | Sponsored
Sell NVDA Now?
Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...
Chaikin Analytics | Sponsored
Musk’s new company could top a trillion?
The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...
Paradigm Press | Sponsored
The #1 Crypto for AI
We’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...
Weiss Ratings | Sponsored
625,000% Gain
The recent crypto correction has shaken many investors, causing panic and uncertainty. But while others are fr...
Crypto Swap Profits | Sponsored